Bio-Techne Corporation (NASDAQ: TECH) and B-MoGen Biotechnologies, Inc. disclosed that Bio-Techne has made a seed investment in B-MoGen. The two have also have also struck a deal by which Bio-Techne would get access to gene editing technology.
Bio-Techne's CTO, Fernando Bazan, commented, "B-MoGen is a terrific investment in an emerging field of novel molecular and discovery tools that not only drives new science at a dizzying pace, but also provides a strong technological foundation for Bio-Techne to explore new generations of high-quality protein, antibody and cellular reagents, build innovative assays and instruments, and continue strongly as the leader in this life science field. We look forward to working closely with B-MoGen scientists."
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Similarly, B-MoGen Biotechnologies CFO, Kristin Taylor Geisler, said, "We are pleased and excited to be working with Bio-Techne, and deploying our gene editing technology in an innovative effort to improve certain Bio-Techne products. While B-MoGen technology has tremendous therapeutic potential, we are just as interested in using the technology in products that enable life science research. The market reach of Bio-Techne will allow the benefits of B-MoGen gene editing to rapidly reach the broad market of researchers who rely on quality reagents to conduct their investigations."
Bio-Techne was excited to engage B-MoGen's unique expertise to explore the use of fresh gene editing technologies to continue enhancing the production, bioactivity and quality of their market-leading protein and antibody reagents.
On Tuesday, shares of the company traded 7.77 percent higher.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.